{"id":"pifb-with-adjuvants","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Myalgia"}]},"_chembl":{"chemblId":"CHEMBL373625","moleculeType":"Small molecule"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PIFB (Poly-ICLC with adjuvants) functions as a toll-like receptor (TLR) agonist that stimulates pattern recognition receptors to enhance antigen presentation and T-cell activation. The adjuvant formulation is intended to boost immunogenicity and promote anti-tumor immune responses. This approach leverages innate immune activation to drive adaptive immunity against cancer cells.","oneSentence":"PIFB is a polyinosinic-polycytidylic acid (poly I:C) based immunostimulatory vaccine formulation designed to activate innate and adaptive immune responses against tumor antigens.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:00:20.507Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer immunotherapy (investigational use with various tumor types)"}]},"trialDetails":[{"nctId":"NCT05676814","phase":"PHASE4","title":"Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-03-24","conditions":"Analgesia, Sternotomy","enrollment":31}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"PIFB with adjuvants","genericName":"PIFB with adjuvants","companyName":"Wake Forest University Health Sciences","companyId":"wake-forest-university-health-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PIFB is a polyinosinic-polycytidylic acid (poly I:C) based immunostimulatory vaccine formulation designed to activate innate and adaptive immune responses against tumor antigens. Used for Cancer immunotherapy (investigational use with various tumor types).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}